Miv Therapeutics, Inc. (IVT) Tops Q1 EPS by 1c; offers guidance

Miv Therapeutics, Inc. (NYSE: IVT) reported Q1 EPS of $0.02, $0.01 better than the analyst estimate of $0.01.

GUIDANCE:

Miv Therapeutics, Inc. sees FY2023 EPS of $0.06-$0.11, versus the consensus of $0.12.

For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c